Stevanato to invest in ICOcap® manufacturing

Stevanato announced in their industrial plan for 2020 – 2023 that they intend to invest almost Euro 400 million in manufacturing and R&D programs for drug delivery systems. A share of this investment will be allocated to the manufacturing of ICOcap®. This update follows the announcement May 27 that ICOcap® received a CE-mark.

Stevanato also recently launched a new product site to increase the visibility of ICOcap® underlining its position as an important product for the future, where Iconovo is featured as a service provider for customizations and formulation services.  

To find the press release for Stevanato’s industrial plan:

To find Stevanato’s new ICOcap® site:

To read more about the CE-mark of ICOcap®: